Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Analytical Cellular Pathology
Analytical Cellular Pathology is not currently indexed in Scopus, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 0921-8912Verify ISSN ↗1878-3651Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Analytical Cellular Pathology indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (1989–2003).
What is the impact factor of Analytical Cellular Pathology?
Analytical Cellular Pathology has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
How much does it cost to publish in Analytical Cellular Pathology?
The publisher lists an article processing charge of about US$2,160 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Analytical Cellular Pathology and what is its ISSN?
Analytical Cellular Pathology is published by John Wiley and Sons Ltd. Its print ISSN is 0921-8912 and its online ISSN is 1878-3651.
Is Analytical Cellular Pathology in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Analytical Cellular Pathology open access?
Yes — it is an open-access journal, listed in DOAJ.
Scopus coverage history
Scopus indexed Analytical Cellular Pathology for 15 years, between 1989 and 2003. Coverage ended in 2003, 23 years ago, and Scopus now lists the title as inactive.
How well cited is Analytical Cellular Pathology? — open metrics via OpenAlex
Analytical Cellular Pathology has an h-index of 60 and a 2-year mean of 1.6 citations per paper (OpenAlex).
Analytical Cellular Pathology published 34 papers in 2025; its busiest recent year was 2022 with 77. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in Analytical Cellular Pathology? — latest 99 articles, 2023–2026
In its latest 99 research articles (2023–2026), authors are most often from China (70.2%), Iran (6.6%) and Türkiye (4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Analytical Cellular Pathology? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2003. 26 retracted papers are recorded (20.3 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2003
- Retracted papers 26 · 20.3 per 1,000 papers
- Problematic Paper Screener flags 2 · 1.6 per 1,000 papers — mostly tortured phrases
- Author concentration70.2% of recent authorship from China
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from John Wiley and Sons Ltd
John Wiley and Sons Ltd has 391 other titles in our data; 317 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.